---
title: "美国食品药品监督管理局批准简化患者监测要求并删除百时美施贵宝细胞疗法标签中的 REMS 计划。"
description: "美国食品药品监督管理局批准简化患者监测要求并删除百时美施贵宝细胞疗法标签中的 REMS 计划。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/246345546.md"
published_at: "2025-06-27T02:09:14.000Z"
---

# 美国食品药品监督管理局批准简化患者监测要求并删除百时美施贵宝细胞疗法标签中的 REMS 计划。

美国食品药品监督管理局批准简化患者监测要求并删除百时美施贵宝细胞疗法标签中的 REMS 计划。

### Related Stocks

- [BMY.US - 百时美施贵宝](https://longbridge.com/zh-CN/quote/BMY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Pfizer Targets Real-World Myeloma Data in Taiwan With New Elranatamab Study | Pfizer Inc. (PFE) is launching a new observational study in Taiwan to evaluate the effectiveness of its multiple myeloma | [Link](https://longbridge.com/zh-CN/news/276252273.md) |
| ICICI Prudential Asset Management Co Ltd Grows Stock Holdings in Bristol Myers Squibb Company $BMY | ICICI Prudential Asset Management Co Ltd increased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 85.8% in Q3,  | [Link](https://longbridge.com/zh-CN/news/276444619.md) |
| Berkshire Hathaway Bought New York Times Stock in Q4. Should You Add NYT to Your Portfolio Too? | Berkshire Hathaway Bought New York Times Stock in Q4. Should You Add NYT to Your Portfolio Too? | [Link](https://longbridge.com/zh-CN/news/276265837.md) |
| Hasbro Enters Into Fourth Amended Revolving Credit Agreement | Hasbro Inc :HASBRO INC - ENTERS INTO FOURTH AMENDED REVOLVING CREDIT AGREEMENT - SEC FILINGHASBRO INC - SECURES $1.1 BIL | [Link](https://longbridge.com/zh-CN/news/276493551.md) |
| What Analysts Are Saying About Bristol-Myers Squibb Stock | 16 analysts have evaluated Bristol-Myers Squibb (NYSE:BMY), revealing mixed sentiments with 4 bullish, 3 somewhat bullis | [Link](https://longbridge.com/zh-CN/news/276477307.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。